Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease-Reference-Cited by-同舟云学术

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease

Published:2019-09-19 Issue:4 Volume:49 Page:365-385
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Merle M.¹,Fischbacher D.¹,Liepert A.¹,Grabrucker C.¹,Kroell T.¹,Kremser A.¹,Dreyssig J.¹,Freudenreich M.¹,Schuster F.²,Borkhardt A.²,Kraemer D.³,Koehne C.-H.³,Kolb H. J.¹⁴,Schmid C.⁵,Schmetzer H. M.¹⁴

Affiliation:

1. Department for Hematopoietic Transplantations, Med III, University Hospital of Munich, Munich, Germany

2. Department for Pediatric Hematology and Oncology, University Hospital of Düsseldorf, Düsseldorf, Germany

3. Department for Hematology, Municipal Hospital Oldenburg, Oldenburg, Germany

4. Helmholtz Center, Clinical Cooperative Group Human Cell Transplantation (CCG-HCT), Munich, Germany

5. Department for Hematology, University Hospital Augsburg, Augsburg, Germany

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2019.1661429

Reference98 articles.

1. The Inflammatory Chemokine CCL5 and Cancer Progression

2. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

3. Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma

4. Heparanase enhances myeloma progression via CXCL10 downregulation

5. Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML);Cancers;2023-09-14

2. CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them;HemaSphere;2023-08-18

3. MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway;Oncotarget;2022-11-02

4. Screening and in Silico Functional Analysis of MiRNAs Associated with Acute Myeloid Leukemia Relapse;MicroRNA;2022-11

5. Influence of probiotics on the periodontium, the oral microbiota and the immune response during orthodontic treatment in adolescent and adult patients (ProMB Trial): study protocol for a prospective, double-blind, controlled, randomized clinical trial;BMC Oral Health;2022-04-27